Robert Beckman, M.D., Professor of Oncology and of Biostatistics, Bioinformatics, and Biomathematics at Georgetown University Medical Center, is an oncology clinical researcher and mathematical biologist who has played significant leadership roles in developing new oncology clinical research groups at 4 pharmaceutical companies and in 5 cross-company collaborations, and brought 23 new oncology therapies into man, and 2 to market. Dr. Beckman’s theoretical studies of cancer evolution predicted broad features of tumor evolution before experimental results were available, and have more recently led to a new approach to cancer precision medicine, dynamic precision medicine, which holds promise for significant improvement in patient outcomes. He has also co-invented novel clinical study designs and development strategies for oncology and rare diseases, and leads the DahShu Innovative Design Scientific Working Group, a 250-person international group in this field. Dr. Beckman’s versatile publication record of over 300 articles, patents, and presentations ranges from computational chemistry to clinical oncology, emphasizing quantitative approaches.